Clinical, angiographic, and operative data of study patients (n = 24)
| Number (%) | |
|---|---|
| ACE, angiotensin converting enzyme; CABG, coronary artery bypass grafting; EF, ejection fraction; NYHA, New York Heart Association; PTCA, percutaneous coronary angioplasty. | |
| EF 25–40% | 17 (71%) |
| EF <25% | 7 (29%) |
| History of myocardial infarction | 17 (71%) |
| Stable angina | 17 (71%) |
| Dyspnoea (NYHA I–II) | 7 (29%) |
| Dyspnoea (NYHA III–IV) | 10 (42%) |
| Q waves on ECG | 15 (63%) |
| Previous CABG | 1 (4%) |
| Previous PTCA | 1 (4%) |
| Diabetes | 5 (21%) |
| Hypertension | 14 (58%) |
| Hyperlipidaemia | 20 (83%) |
| Smoking | 15 (63%) |
| β Blockers | 18 (75%) |
| Calcium blockers | 9 (38%0 |
| Long acting nitrates | 7 (29%) |
| ACE inhibitors | 18 (75%) |
| Diuretics | 9 (38%) |
| Two vessel disease | 3 (12%) |
| Three vessel disease | 21 (88%) |
| Number of distal coronary anastomoses | |
| 2 | 3 (12%) |
| 3 | 5 (21%) |
| 4 | 15 (63%) |
| 5 | 1 (4%) |